HUP0004661A3 - Polyhydroxybutylpyrazines, their preparation and medicines containing them - Google Patents

Polyhydroxybutylpyrazines, their preparation and medicines containing them

Info

Publication number
HUP0004661A3
HUP0004661A3 HU0004661A HUP0004661A HUP0004661A3 HU P0004661 A3 HUP0004661 A3 HU P0004661A3 HU 0004661 A HU0004661 A HU 0004661A HU P0004661 A HUP0004661 A HU P0004661A HU P0004661 A3 HUP0004661 A3 HU P0004661A3
Authority
HU
Hungary
Prior art keywords
polyhydroxybutylpyrazines
preparation
medicines containing
medicines
Prior art date
Application number
HU0004661A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of HUP0004661A2 publication Critical patent/HUP0004661A2/hu
Publication of HUP0004661A3 publication Critical patent/HUP0004661A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HU0004661A 1997-07-17 1998-07-15 Polyhydroxybutylpyrazines, their preparation and medicines containing them HUP0004661A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9709059A FR2766183B1 (fr) 1997-07-17 1997-07-17 Medicaments contenant des polyhydroxybutylpyrazines, les polyhydroxybutylpyrazines nouvelles et leur preparation
PCT/FR1998/001543 WO1999003841A1 (fr) 1997-07-17 1998-07-15 Polyhydroxybutylpyrazines, leur preparation et medicaments les contenant

Publications (2)

Publication Number Publication Date
HUP0004661A2 HUP0004661A2 (hu) 2001-11-28
HUP0004661A3 true HUP0004661A3 (en) 2001-12-28

Family

ID=9509301

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004661A HUP0004661A3 (en) 1997-07-17 1998-07-15 Polyhydroxybutylpyrazines, their preparation and medicines containing them

Country Status (25)

Country Link
US (1) US6288066B1 (hu)
EP (1) EP1001942B1 (hu)
JP (1) JP4443033B2 (hu)
KR (1) KR20010021871A (hu)
CN (1) CN1264368A (hu)
AT (1) ATE243683T1 (hu)
AU (1) AU745905B2 (hu)
BR (1) BR9810595A (hu)
CA (1) CA2296725C (hu)
CZ (1) CZ290896B6 (hu)
DE (1) DE69815854T2 (hu)
DK (1) DK1001942T3 (hu)
ES (1) ES2196595T3 (hu)
FR (1) FR2766183B1 (hu)
HU (1) HUP0004661A3 (hu)
IL (1) IL134039A0 (hu)
MX (1) MXPA00000437A (hu)
NO (1) NO20000199L (hu)
NZ (1) NZ502279A (hu)
PL (1) PL338147A1 (hu)
PT (1) PT1001942E (hu)
RU (1) RU2186773C2 (hu)
SK (1) SK462000A3 (hu)
WO (1) WO1999003841A1 (hu)
ZA (1) ZA986336B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802815A1 (fr) * 1999-12-23 2001-06-29 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique agoniste du recepteur gamma-active par le proliferateur de peroxisome
FR2802813A1 (fr) * 1999-12-23 2001-06-29 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique de la famille des biguandes
FR2802816A1 (fr) * 1999-12-23 2001-06-29 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique inhibiteur d'alpha-glucosidase
US6794506B2 (en) * 2000-07-21 2004-09-21 Elan Pharmaceuticals, Inc. 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
DE102005047647A1 (de) * 2005-10-05 2007-04-12 Merck Patent Gmbh a,a'-Dihydroxyketonderivate und deren Verwendung als UV-Filter
CN101970409A (zh) 2007-03-19 2011-02-09 帝斯曼知识产权资产管理有限公司 紫外光遮蔽剂化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2744365B1 (fr) * 1996-02-06 1998-02-27 Inst Malgache Rech Appl Melanges isolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments

Also Published As

Publication number Publication date
RU2186773C2 (ru) 2002-08-10
IL134039A0 (en) 2001-04-30
DE69815854T2 (de) 2004-05-13
PL338147A1 (en) 2000-09-25
SK462000A3 (en) 2000-06-12
ES2196595T3 (es) 2003-12-16
US6288066B1 (en) 2001-09-11
FR2766183A1 (fr) 1999-01-22
KR20010021871A (ko) 2001-03-15
ZA986336B (en) 1999-01-27
CN1264368A (zh) 2000-08-23
DE69815854D1 (de) 2003-07-31
HUP0004661A2 (hu) 2001-11-28
EP1001942A1 (fr) 2000-05-24
AU745905B2 (en) 2002-04-11
ATE243683T1 (de) 2003-07-15
FR2766183B1 (fr) 1999-08-27
JP4443033B2 (ja) 2010-03-31
BR9810595A (pt) 2000-09-12
WO1999003841A1 (fr) 1999-01-28
NO20000199D0 (no) 2000-01-14
CZ2000121A3 (cs) 2000-05-17
MXPA00000437A (es) 2002-04-17
DK1001942T3 (da) 2003-10-20
NZ502279A (en) 2002-04-26
CA2296725C (fr) 2008-11-18
CZ290896B6 (cs) 2002-11-13
NO20000199L (no) 2000-01-14
PT1001942E (pt) 2003-11-28
AU8810398A (en) 1999-02-10
EP1001942B1 (fr) 2003-06-25
JP2001510185A (ja) 2001-07-31
CA2296725A1 (fr) 1999-01-28

Similar Documents

Publication Publication Date Title
SG87776A1 (en) Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals
PL340337A1 (en) Drugs
PL346530A1 (en) Azetidine derivatives, preparation and medicines containing them
IL141769A0 (en) Azetidine derivatives, preparation and medicines containing them
HK1078561A1 (en) Novel compounds, their use and preparation
PL319342A1 (en) Drugs
HUP9601555A2 (en) Microcapsule composition, preparation thereof, pesticidal composition and use thereof
IL119994A0 (en) 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazolidinones their preparation and pharmaceutical compositions containing them
HUP0103884A3 (en) Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use
PL343512A1 (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
HUP0000762A3 (en) 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines, and pharmaceutical compositions containing them
HUP0002272A3 (en) Aroyl-piperazine derivatives, their preparation pharmaceutical compositions containing them and their use
HUP9802132A3 (en) Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them
HUP9802408A3 (en) Naphthyl and dihydronaphthyl-derivatives, and pharmaceutical compositions, containing them
GB9702021D0 (en) Medicaments
IL117067A (en) Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz¬b,f¾oxepines their preparation and pharmaceutical compositions containing them
GB9718791D0 (en) Medicaments
ZA982073B (en) Pharmaceutical preparation
HUP9903715A3 (en) 25-hydroxy-16-ene-26,27-bishomo-cholecalciferols, their use and medicaments containing them
GB9506844D0 (en) Pharmaceutical microencapsulation
HUP0004661A3 (en) Polyhydroxybutylpyrazines, their preparation and medicines containing them
HUP9802590A3 (en) Indan-, benzothiophene-, benzofuran- and indolesulfonamide derivatives, their use and pharmaceutical compositions containing them
ZA9811344B (en) New azulene derivatives and medicaments containing same
HUP0002821A3 (en) Polyhydroxyalkylpyrazine derivatives, preparation and medicines containing them
HUP0002403A3 (en) Polyhydroxyalkylpyrazine derivatives, their preparation and medicines containing them